TG Therapeutics Inc. logo

TG Therapeutics Inc.

TGTX | NASDAQ
Chart Builder DCF Calculator
$57.90
+$0.74 (+1.29%)
Sep 22, 2026, 11:27 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
447.18M 23.38M 12.67M -198.34M -348.1M -279.38M
Depreciation & Amortization
59K 280K 423K 515K 494K 374K
Stock-Based Compensation
64.67M 42.54M 37.93M 19.19M 61.27M 80.29M
Other Working Capital
-40.52M 35.65M 3.18M 7.97M -10.83M -31.39M
Other Non-Cash Items
5.86M 2.58M 2.22M 4.11M 2.4M 4M
Deferred Income Tax
-348M n/a n/a n/a 517K -30K
Change in Working Capital
-194.54M -109.3M -84.66M -1.65M -12.22M -19.76M
Operating Cash Flow
-24.77M -40.52M -31.41M -176.17M -295.63M -214.51M
Capital Expenditures
-214K -45K n/a -14K -401K -357K
Cash Acquisitions
n/a n/a n/a 20M -69K 24.15M
Purchase of Investments
-223.49M -311.89M -146.88M -107.27M -55.53M -67.4M
Sales Maturities Of Investments
237.5M 310.9M 96.23M 87.28M 55.6M 43.25M
Other Investing Acitivies
n/a n/a n/a -20M 69K -24.15M
Investing Cash Flow
13.8M -1.04M -50.65M -20.01M -332K -24.51M
Debt Repayment
n/a 137.26M 25M -975K 40M n/a
Common Stock Repurchased
-91.24M -8.76M n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 25K 1.41M n/a -800K 147K
Financial Cash Flow
-89.73M 128.53M 72.71M -391K 41.42M 679.83M
Net Cash Flow
-100.7M 86.97M -9.36M -196.57M -254.55M 440.81M
Free Cash Flow
-24.99M -40.56M -31.41M -176.18M -296.04M -214.86M
Adj. Free Cash Flow
-89.66M -83.1M -69.35M -195.37M -357.31M -295.15M
Maintenance CapEx
n/a n/a n/a -14K n/a -357K
Growth CapEx
-214K -45K n/a n/a -401K n/a
Owner Earnings
-24.77M -40.52M -31.41M -176.18M -295.63M -214.86M

© 2026 bestshares.com. All rights reserved.